Author

Mary Bravo

Institutions: Centers for Disease Control and Prevention, Puerto Rico Department of Health

Observed institutions: Centers for Disease Control and Prevention, Puerto Rico Department of Health

OpenAlex ID: A5114053729

Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease

2023 · Connie A Haley, Marcos C Schechter, et al. · Clinical Infectious Diseases · 50

Works count: 1

Citation count: 50

H-index: 1

I10-index: 1